Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...

The patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.

On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...

Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...

Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog ...

The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo for its National Coverage Analysis (NCA) ...

The S&P 500 Index ($SPX) (SPY) today is down -0.57%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.65%, and the ...

Medtronic reported that it has begun testing an expansion of its renal denervation approach for dropping stubbornly high blood pressure, by also treating vessels outside of the kidneys.&n | The ...

Recall that Medtronic acquired the renal denervation technology from Mountain View, California-based Ardian back in 2010 for $800 million plus milestone payments.

Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), today announced their support for ...